A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients
Mol Psychiatry
.
2016 Oct;21(10):1483-4.
doi: 10.1038/mp.2016.140.
Epub 2016 Aug 16.
Authors
M Fava
,
K Johe
,
L Ereshefsky
,
L G Gertsik
,
B A English
,
J A Bilello
,
L M Thurmond
,
J Johnstone
,
B C Dickerson
,
N Makris
,
B B Hoeppner
,
M Flynn
,
D Mischoulon
,
G Kinrys
,
M P Freeman
PMID:
27528461
PMCID:
PMC5030463
DOI:
10.1038/mp.2016.140
No abstract available
Publication types
Published Erratum